Literature DB >> 19744402

Treatment options for obstructive sleep apnea.

Vivien C Abad1, Christian Guilleminault.   

Abstract

Sleep apnea is a major public health problem that afflicts 9% of women and 24% of men 30 to 60 years of age. It is highly treatable, but when untreated, it has been associated with (but not necessarily linked to) increased probability of cerebral and coronary vascular disease, congestive heart failure, metabolic dysfunction, cognitive dysfunction, excessive daytime sleepiness, motor vehicle accidents, reduced productivity, and decreased quality of life. The gold standard for treatment in adults is positive airway pressure (PAP) therapy: continuous PAP (CPAP), bilevel PAP, autotitrating CPAP, or autotitrating bilevel PAP. Measures to increase compliance with PAP therapy include medical or surgical treatment of any underlying nasal obstruction, setting appropriate pressure level and airflow, mask selection and fitting, heated humidification, desensitization for claustrophobia, patient and partner education, regular follow-up with monitoring of compliance software, and attendance of support groups (eg, AWAKE). Adjunctive treatment modalities include lifestyle or behavioral measures and pharmacologic therapy. Patients with significant upper airway obstruction who are unwilling or unable to tolerate PAP therapy may benefit from surgery. Multilevel surgery of the upper airway addresses obstruction of the nose, oropharynx, and hypopharynx. A systematic approach may combine surgery of the nose, pharynx, and hypopharynx in phase 1, whereas skeletal midface advancement or tracheotomy constitutes phase 2. Clinical outcomes are reassessed through attended diagnostic polysomnogram performed 3 to 6 months after surgery. Oral appliances can be used for patients with symptomatic mild or moderate sleep apnea who prefer them to PAP therapy or for whom PAP therapy has failed or cannot be tolerated. Oral appliances also may be used for patients with severe obstructive sleep apnea who are unable or unwilling to undertake PAP therapy or surgery. For children, the main treatment modality is tonsillectomy and adenoidectomy, with or without turbinate surgery. Children with craniofacial abnormalities resulting in maxillary or mandibular insufficiency may benefit from palatal expansion or maxillary/mandibular surgery. PAP therapy may be used for children who are not surgical candidates or if surgery fails.

Entities:  

Year:  2009        PMID: 19744402     DOI: 10.1007/s11940-009-0040-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  40 in total

1.  Re-redefining success in airway surgery for obstructive sleep apnea.

Authors:  Michael Friedman; Meghan Wilson
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

Review 2.  Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review.

Authors:  Karl A Franklin; Heidi Anttila; Susanna Axelsson; Thorarinn Gislason; Paula Maasilta; Kurt I Myhre; Nina Rehnqvist
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

3.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

4.  Distraction osteogenesis in correction of micrognathia accompanying obstructive sleep apnea syndrome.

Authors:  Xing Wang; Xiao-Xia Wang; Cheng Liang; Biao Yi; Ye Lin; Zi-Li Li
Journal:  Plast Reconstr Surg       Date:  2003-11       Impact factor: 4.730

Review 5.  Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.

Authors:  C McDaid; S Griffin; H Weatherly; K Durée; M van der Burgt; S van Hout; J Akers; R J O Davies; M Sculpher; M Westwood
Journal:  Health Technol Assess       Date:  2009-01       Impact factor: 4.014

6.  Long-term compliance and side effects of oral appliances used for the treatment of snoring and obstructive sleep apnea syndrome.

Authors:  Fernanda Ribeiro de Almeida; Alan A Lowe; Satoru Tsuiki; Ryo Otsuka; Mary Wong; Sandra Fastlicht; Frank Ryan
Journal:  J Clin Sleep Med       Date:  2005-04-15       Impact factor: 4.062

7.  Sleep disordered breathing: surgical outcomes in prepubertal children.

Authors:  Christian Guilleminault; Kasey K Li; Andrei Khramtsov; Rafael Pelayo; Sandra Martinez
Journal:  Laryngoscope       Date:  2004-01       Impact factor: 3.325

8.  Redefining success in airway surgery for obstructive sleep apnea: a meta analysis and synthesis of the evidence.

Authors:  Adam G Elshaug; John R Moss; Anne Marie Southcott; Janet E Hiller
Journal:  Sleep       Date:  2007-04       Impact factor: 5.849

Review 9.  Epidemiology of pediatric obstructive sleep apnea.

Authors:  Julie C Lumeng; Ronald D Chervin
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

10.  Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.

Authors:  Thomas Roth; Gregory A Rippon; Sanjay Arora
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

View more
  5 in total

1.  Comparison of adjustable and fixed oral appliances for the treatment of obstructive sleep apnea.

Authors:  Christopher J Lettieri; Nathalie Paolino; Arn H Eliasson; Anita A Shah; Aaron B Holley
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

2.  Sleep and headache.

Authors:  Jeanetta C Rains; J Steven Poceta
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

3.  The effect of geniglossal advancement on airway flow using a computational flow dynamics model.

Authors:  Aaron Fletcher; Jiwoong Choi; Maged Awadalla; Andrea E Potash; Tanner J Wallen; Steven Fletcher; Eugene H Chang
Journal:  Laryngoscope       Date:  2013-05-31       Impact factor: 3.325

Review 4.  Updates in oral appliance therapy for snoring and obstructive sleep apnea.

Authors:  Hui Chen; Alan A Lowe
Journal:  Sleep Breath       Date:  2012-05-06       Impact factor: 2.816

5.  Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension.

Authors:  Marcia C Feres; Fatima D Cintra; Camila F Rizzi; Luciane Mello-Fujita; Altay A Lino de Souza; Sergio Tufik; Dalva Poyares
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.